GlaxoSmithKlineE Balance Sheet Health
Financial Health criteria checks 6/6
GlaxoSmithKlineE has a total shareholder equity of EGP1.9B and total debt of EGP0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are EGP4.0B and EGP2.1B respectively. GlaxoSmithKlineE's EBIT is EGP482.7M making its interest coverage ratio -34.4. It has cash and short-term investments of EGP566.7M.
Key information
0%
Debt to equity ratio
ج.م0
Debt
Interest coverage ratio | -34.4x |
Cash | ج.م566.74m |
Equity | ج.م1.88b |
Total liabilities | ج.م2.09b |
Total assets | ج.م3.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIOC's short term assets (EGP3.1B) exceed its short term liabilities (EGP2.0B).
Long Term Liabilities: BIOC's short term assets (EGP3.1B) exceed its long term liabilities (EGP119.3M).
Debt to Equity History and Analysis
Debt Level: BIOC is debt free.
Reducing Debt: BIOC has no debt compared to 5 years ago when its debt to equity ratio was 6%.
Debt Coverage: BIOC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BIOC has no debt, therefore coverage of interest payments is not a concern.